From December 1, 2023 to February 29, 2024, the company has repurchased 30,000 shares, representing 0.03% for CAD 0.03 million. With this, the company has completed the repurchase of 1,006,394 shares, representing 1.11% for CAD 0.94 million under the buyback announced on November 30, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 CAD | 0.00% |
|
+1.45% | -15.66% |
1st Jan change | Capi. | |
---|---|---|
-15.66% | 46.01M | |
+29.63% | 261M | |
+2.06% | 211M | |
+25.00% | 167M | |
+39.13% | 130M | |
+300.00% | 121M | |
-54.42% | 103M | |
-28.57% | 96.6M | |
+71.19% | 96.17M | |
-23.08% | 66.82M |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.